Physiotherapy in cystic fibrosis: Optimising techniques to improve outcomes

Paediatric Respiratory Reviews

Volumn 14, Issue 4, 2013, Pages 263-269

  Rand, S ^a,b   Hill, L ^a   Prasad, S A ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Airway clearance therapy; Cystic fibrosis; Exercise; Inhalation therapy; Physiotherapy

Indexed keywords

ANTIBIOTIC AGENT; DORNASE ALFA; SALBUTAMOL; SODIUM CHLORIDE;

ARTIFICIAL VENTILATION; BREATHING EXERCISE; CHILD HEALTH CARE; CYSTIC FIBROSIS; DRUG DELIVERY DEVICE; DRUG TOLERABILITY; EXERCISE; EXERCISE TEST; FACE MASK; HEALTH CARE MANAGEMENT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTRAPULMONARY PERCUSSIVE VENTILATION; LUNG CLEARANCE; NEBULIZER; NEWBORN SCREENING; NONINVASIVE VENTILATION; PATIENT COMPLIANCE; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; VENTILATOR;

AIRWAY CLEARANCE THERAPY; CYSTIC FIBROSIS; EXERCISE; INHALATION THERAPY; PHYSIOTHERAPY;

CYSTIC FIBROSIS; HUMANS; INCIDENCE; INFANT, NEWBORN; NEONATAL SCREENING; PHYSICAL THERAPY MODALITIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; WORLD HEALTH;

EID: 84887402967     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2012.08.006     Document Type: Review

References (62)

1. Robertson C.F. How do we choose a therapeutic regimen in cystic fibrosis?. Thorax 2002, 57:839-840.
2. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. European Respiratory Journal 2007, 29:522-526.
3. Daniels T. Physiotherapeutic management strategies for the treatment of cystic fibrosis in adults. Journal of Mulitdisciplinary Healthcare 2010, 3:201-212.
4. Elkins M.R., Robinson M., Rose B.R., Harbour C., Moriarty C.P., Marks G.B., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine 2006, 354:229-240.
5. Robinson M., Hemming A.L., Regnis J.A., Wong A.G., Bailey D.L., Bautovich G.J., et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997, 52:900-903.
6. Robinson M., Regnis J.A., Bailey D.L., King M., Bautovich G.J., Bye P.T. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996, 153:1503-1509.
7. Donaldson S.H., Bennett W.D., Zeman K.L., Knowles M.R., Tarran R., Boucher R.C. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine 2006, 354:241-250.
8. King M., Dasgupta B., Tomkiewicz R.P., Brown N.E. Rheology of Cystic Fibrosis Sputum after in vitro Treatment with Hypertonic Saline Alone and in Combination with Recombinant Human Deoxyribonuclease I. Am J Respir Crit Care Med 1997, 156:173-177.
9. Eng P.A., Morton J., Douglass J.A., Riedler J., Wilson J., Robertson C.F. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996, 21:77-83.
10. Dentice R., Elkins M. Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database Syst Rev 2012, CD008816.
11. Dentice R., Elkins M.R., Bye P.T. Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy 2012, 58:33-40.
12. Kearney C.E., Wallis C.E. Deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2000, C001127D.
13. Jones A.P., Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2010, CD001127.
14. Suri R., Metcalfe C., Lees B., Grieve R., Flather M., Normand C., et al. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis. Lancet 2002, 358:1316-1321.
15. Shak S., Caopn D.J., Hellmiss R., Marsters S.A., Baker C.L. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:9188-9192.
16. Dentice R., Elkin M. Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev 2011, CD007923.
17. Anderson P., Morton J. Evaluation of two different timings of Pulmozyme nebulisation in relation to chest physiotherapy in children with Cystic Fibrosis. J Cyst Fibros 2009, 8(Suppl 2):S74.
18. van der Giessen L.J., de Jongste J.C., Gosselink R., Hop W.C., Tiddens H.A. RhDNase before airway clearacne therapy improves airway patency in children with CF. Pediatr Pulmonol 2007, 42:624-630.
19. Daniels T., Goodacre L., Sutton C., Pollard K., Conway S., Peckham D. Accurate Assessment of Adherence: Self-Report and Clinican Report vs Electronic Monitoring of Nebulisers. Chest 2011, 140:425-432.
20. Lannefors L., Button B.M., McIlwaine M. Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments. J R Soc Med 2004, 97(Suppl 44):8-25.
21. Lannefors L., Heslop K., Teirlinck C. Nebuliser systems, contamination, microbial risks, cleaning and effect on function. European Respiratory Review 2000, 10:571e5.
22. Sawicki G.S., Sellers D.E., Robinson W.M. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009 Mar, 8:91-96.
23. ACPCF. Association of Chartered Physiotherapists in Cystic Fibrosis: Clinical Guidelines for the Physiotherapy Management of Cystic Fibrosis: recommendations of a working group. Cystic Fibrosis Trust. 2010. http://wwwcftrustorguk/.
24. Elkins M.R., Bye P.T. Inhaled hypertonic saline as a therapy for cystic fibrosis. Current Opinion in Pulmonary Medicine 2006, 12:445-452.
25. Stites S.W., Perry G.V., Peddicord T., Cox G., McMillan C., Becker B. Effect of high-frequency chest wall oscillation on the central and peripheral distribution of aerosolized diethylene triamine penta-acetic acid as compared to standard chest physiotherapy in cystic fibrosis. Chest 2006 Mar, 129:712-717.
26. ®) inhalation in COPD patients. Pneumologie 2001, 55:465-469.
27. Laube B.L., Geller D.E., Lin T., Dalby R.N., Diener-West M., Zeitlin P.L. Positive Expiratory Pressure Changes Aerosol Distribution in Patients with Cystic Fibrosis. Respir Care 2005, 50:1438-1444.
28. Bradley J., Moran F. Physical training for cystic fibrosis. Cochrane Database Syst Rev 2011, CD002768.
29. van der Schans C., Prasad A., Main E. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst Rev 2000, CD001401.
30. Main E., Prasad A., Schans C. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev 2005, CD002011.
31. Pryor J.A., Tannenbaum E., Scott S.F., Burgess J., Cramer D., Gyi K., et al. Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis. J Cyst Fibros 2010 May, 9:187-192.
32. BTS Non-invasive ventilation in acute respiratory failure. Thorax 2002, 57:192-211.
33. Moran F., Bradley J.M., Piper A.J. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev 2009, CD002769.
34. Fauroux B. Why, when and how to propose noninvasive ventilation in cystic fibrosis?. Minerva Anestesiologica 2011, 77:1108-1114.
35. Flight W.G., Shaw J., Johnson S., Webb A.K., Jones A.M., Bentley A.M., et al. Long-term non-invasive ventilation in cystic fibrosis - Experience over two decades. J Cyst Fibros 2012, 11:187-192.
36. Holland A.E., Denehy L., Ntoumenopoulos G., Naughton M.T., Wilson J.W. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 2003, 58:10.
37. Fauroux B. Noninvasive ventilation in cystic fibrosis. Expert Reviews 2010, 4:39-46.
38. Newhouse P.A., White F., Marks J.H., Homnick D.N. The intrapulmonary percussive ventilator and flutter device compared to standard chest physiotherapy in patients with cystic fibrosis. Clinical Paediatrics 1998, 37:427-432.
39. Natale J.E., Pfeile J., Homnick D.N. Comparison of intrapulmonary percussive ventilation and chest physiotherapy. A pilot study in patients with cystic fibrosis. Chest 1994, 105:1789-1793.
40. Homnick D.N., White F., De Castro C. Comparison of the effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatr Pulmonol 1995, 20:50-55.
41. Prasad S.A., Main E. Finding evidence to support airway clearance techniques in cystic fibrosis. Disabil Rehabil 1998, 20:235-246.
42. Oermann C.M., Swank P.R., Sockrider M.M. Validation of an instrument measuring patient satisfaction with chest physiotherapy techniques in cystic fibrosis. Chest 2000, 118:92-97.
43. Prasad A., Main E., Dodd M.E. Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis. Pediatr Pulmonol 2008, 43:236-244.
44. Goss C.H. Airway Clearance in Cystic Fibrosis. Respir Care 2003, 48:20-21.
45. Prasad A., Main E. Routine airway clearance in asymptomatic infants and babies with cystic fibrosis in the UK: obligatory or obsolete?. Phys Ther 2006, 11:11-20.
46. Button B.M., Heine R.G., Catto-Smith A.G., Olinsky A., Phelan P.D., Ditchfield M.R., et al. Chest Physiotherapy in Infants With Cystic Fibrosis: To Tip or Not?. A Five-Year Study. Pediatr Pulmonol 2003, 35:208-213.
47. Van Ginderdeuren F., Malfroot A., Verdonk J., Vanlaethem S., Vandenplas Y. Influence of assisted autogenic drainage (AAD) and AAD combined with bouncing on gastro-oesophageal reflux (GOR) in infants under the age of 5 months. J Cyst Fibros 2003, 2(Suppl 1):A251.
48. Wheatley C.M., Wilkins B.W., Snyder E.M. Exercise Is Medicine in Cystic Fibrosis. Exercise and Sport Sciences Reviews 2011, 39:155-160.
49. Williams C.A., Benden C., Stevens D., Radtke T. Exercise Training in Children and Adolescents with Cystic Fibrosis: Theory into Practice. International Journal of Pediatrics 2010, 2010:1-7.
50. van Sluijs E.M.F., McMinn A.M., Griffin S.J. Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials. British Medical Journal 2007, 335:703.
51. Giles-Corti B., Salmon J. Encouraging children and adolescents to be more active. British Medical Journal 2007, 335:677-678.
52. Boucher G.P., Lands L.C., Hay J.A., Hornby L. Activity levels and the relationship to lung function and nutritional status in children with cystic fibrosis. American Journal of Physical and Medical Rehabilitation 1997, 76:311-315.
53. Nixon P.A., Orenstein D.M., Kelsey S.F. Habitual physical activity in children and adolescents with cystic fibrosis. Med Sci Sports Exerc 2001 Jan, 33:30-35.
54. Abu-Hasan M., Armstrong N., Andersen L.B., Weinberger M., Nixon P.A. Exercise in Children during Health and Sickness. International Journal of Pediatrics 2010, 2010:1-2.
55. Dempsey J.M., Kimiecik J.C., Horn T.S. Parental influences on children's moderate to vigorous physical activity participation: an expectancy-value approach. Pediatric Exercise Science 1993, 5:151-167.
56. Stevens D., Oades P.J., Armstrong N., Williams C.A. A survey of exercise testing and training in UK cystic fibrosis clinics. J Cyst Fibros 2010 Sep, 9:302-306.
57. Nixon P.A., Orenstein D.M., Kelsey S.F., Doershuk C.F. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992 Dec 17, 327:1785-1788.
58. Pianosi P., LeBlanc J., Almudevar A. Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis. Pediatr Pulmonol 2005 Oct, 40:324-329.
59. Moorcroft A.J., Dodd M.E., Morris J., Webb A.K. Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial. Thorax 2004, 59:1074-1080.
60. Hebestreit H., Kieser S., Junge S., Ballmann M., Hebestreit A., Schindler C., et al. Long-term effects of a partially supervised conditioning programme in cystic fibrosis. European Respiratory Journal 2010, 35:578-583.
61. Selvadurai H.C., Blimkie C.J., Meyers N., Mellis C.M., Cooper P.J., Van Asperen P.P. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002 Mar, 33:194-200.
62. Klijn P.H., Oudshoorn A., van der Ent C.K., van der Net J., Kimpen J.L., Helders P.J. Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest 2004 Apr, 125:1299-1305.